Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.
about
Sex differences in Parkinson's diseaseThe potential for estrogens in preventing Alzheimer's disease and vascular dementiaSex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex.Effects of oestrogen on cognition: what have we learned from basic research?Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's DiseaseRole of calbindin-D28K in estrogen treatment for Parkinson's disease.Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periodsEstrogen receptor beta expression in the embryonic brain regulates development of calretinin-immunoreactive GABAergic interneurons.Profile of executive and memory function associated with amphetamine and opiate dependenceMenstrual cycle phase modulates reward-related neural function in women.Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease.Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.Drug Insight: new drugs in development for Parkinson's disease.Estrogen, testosterone, and sequential movement in men.Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administrationRapid estrogen signaling in the brain.Genes, Gender, Environment, and Novel Functions of Estrogen Receptor Beta in the Susceptibility to Neurodevelopmental Disorders.Genetic variability in estrogen disposition: Potential clinical implications for neuropsychiatric disorders.Sex differences in the injured brain.Membrane-initiated signaling of estrogen related to neuroprotection. "Social networks" are required.Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.Gender differences in the association between antidepressant use and restless legs syndrome.Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice.Hormone modulation: a novel therapeutic approach for women with severe mental illness.Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice.Mice lacking the Parkinson's related GPR37/PAEL receptor show non-motor behavioral phenotypes: age and gender effect.Effects of long-term hormone treatment and of tibolone on monoamines and monoamine metabolites in the brains of ovariectomised, Cynomologous monkeys.Nomifensine alters sex differences in striatal dopaminergic function.Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice.Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
P2860
Q27025107-69A9E90B-A572-4DAC-96BB-99F75CBDDCAAQ28263673-6A218B44-23F5-465F-9C4E-46D4B9A58ABAQ30474007-0B97A23B-777D-4AFA-9AF7-B4603169ECE2Q30475350-E5FE2F60-8B90-4927-980A-3B47F19995CFQ30478476-57A0C8D7-E3F4-4FB6-AC09-7F82506E6970Q30482834-D8CD7A79-44E2-46D7-8F75-370101400A94Q33257102-F4C95529-3568-4A21-9B59-2D43587AABEDQ33740654-AB250DF0-5978-4D4A-8558-48A1ACF30449Q34095326-E448D257-5D61-476B-AA4A-A6E7A992B957Q35103802-40F4303E-DBDC-4949-9512-7AF0443882F9Q35539953-27275093-1FBE-4A6A-A4B9-CAA61C0E2761Q35789371-70DF2AE6-203F-43CD-B746-EE4D54217E53Q35844615-A62CDBDA-E946-40E5-8622-B1850029AED0Q35971342-B1BE289A-459E-495F-9FDD-E8E4DA41A786Q36020733-20AF8B93-11E7-46E3-BE45-B9166EBB34C2Q36102771-994F4B6E-1551-4F2B-9314-34026E4B6A4AQ36631654-4B5798C6-371F-44EE-820C-A640C3FE5BC8Q36920058-48E90F3F-864F-4535-9845-8C3DBBB8144AQ36969243-37A1835C-2943-491E-A191-21FF2C346716Q37078034-5531EE68-5861-4DF7-AD03-AA239477C421Q37721503-30FEC886-657E-489A-B145-9DF3C4A18276Q37795699-BAEA0EBD-B7B9-4D9D-BC56-9AA0652B3828Q38471576-91DF9D2A-9DF3-440A-9ACA-AC14E4747A50Q38471641-9C53FE4A-4AF6-416A-93A9-978B25EA1E4EQ39428788-CAF17B9A-9A54-4057-A4BB-29815143B774Q44981188-F46E793E-84F5-424B-BE8F-8BB72A6B3D0EQ46057248-CB216E79-1477-42BE-8152-6CD617BDB6FBQ46806999-A64CE018-77C8-41A7-A563-B6B1BA36261EQ46866943-68C03350-2D4F-4A02-9B84-463A4A837DABQ46895969-F0272F4B-6850-4981-A6E1-3132407D847BQ48031082-3DFD493B-727F-44CF-8506-CB909631FFD6Q48458795-EAE6A833-59EC-4419-ADF2-CB4E2E9758F0Q48629326-DC02F197-156A-4A33-9FD0-D2638A102FB2Q51743205-8A26ACFF-63FC-498B-BCBD-337D85976B63Q58784650-ABA70880-B200-4A67-A917-8505C3F3E642
P2860
Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Estrogen as neuroprotectant of ...... boratory and clinical studies.
@ast
Estrogen as neuroprotectant of ...... boratory and clinical studies.
@en
type
label
Estrogen as neuroprotectant of ...... boratory and clinical studies.
@ast
Estrogen as neuroprotectant of ...... boratory and clinical studies.
@en
prefLabel
Estrogen as neuroprotectant of ...... boratory and clinical studies.
@ast
Estrogen as neuroprotectant of ...... boratory and clinical studies.
@en
P356
P1433
P1476
Estrogen as neuroprotectant of ...... boratory and clinical studies.
@en
P2093
Dean Dluzen
Martin Horstink
P2888
P356
10.1385/ENDO:21:1:67
P577
2003-06-01T00:00:00Z
P6179
1048779211